Success Stories: An Assistant Scientist Achieves EB-1A and NIW cases Approval less than 2 Months apart, Now Awaits I-485 Approval With Us

 

Client’s Testimonial:

“Thanks for letting me know about the NIW approval. It’s been a pleasure working with you. For someone with my profile, you guys helped me to get both NIW and EB1A approved. And I am working with you for I-485 for both me and my spouse. Meanwhile, I have already referred you to my friends and a few of them have already signed the contract with you and working. Thank you so much!”


On May 3rd, 2021 and June 16th, 2021, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for an Assistant Scientist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Assistant Scientist

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: May 3rd, 2021 (EB-1A) and June 16th, 2021 (NIW)

Processing Time: 6 months, 9 days (EB-1A) (Premium Processing Requested) and 12 months (NIW)


Case Summary:

An assistant scientist contacted our law firm to help him establish his significant contributions to the U.S. by filing for an EB-2 NIW (National Interest Waiver) petition. We are obligated to evaluate our client’s qualifications and research backgrounds to certify the veracity of their credentials. So, after successfully checking his achievements, we submitted his NIW case to the USCIS. While his NIW petition was pending approval, he went through another notion that filing more than one petition at the same time can lead him to reach green card success sooner. Thus, he retained our services to construct another petition under the EB-1A (Alien of Extraordinary Ability) visa category. Since our priority was to present his exceptional professional background and unparalleled experience important to his current and future work to the USCIS, he is a uniquely valuable scientist who must be allowed to continue researching in the United States.

Thus, we added the following in his NIW and EB1A cases presentation to authenticate:

  • That he held a Ph.D. in biochemistry with extensive experience in researching the isolation and purification of genomic DNA, and native and denaturing electrophoresis techniques, among other molecular biology skills, as well as software skills. We concluded that his research addresses some of our nation’s most pressing issues, including understanding the molecular mechanisms that prevent cancer cells from apoptosis and the disrupting functions of proteins during cancer progression, which contribute to the development of improved cancer therapies.
  • Additionally, we highlighted the 241 citations piled up from 11 peer-reviewed scientific articles and 1 book chapter he published. He is an immensely impactful member of the field, as represented in his vast history of publications in prestigious and high-impact journals. Journal publications are the main means by which research findings are disseminated among the research community, so his consistent success in this domain is a sign of his prominence in the field. Moreover, his work is highly cited in at least 39 countries, demonstrating his work plays a major role in the advancement of research in biomedical science. Besides, he had also conducted 95 peer reviews for top research publications and journals, thereby confirming peer review activity is crucial to the scientific publication process and the academic community at large, and it is an instance of great and trustworthy information and skill within the given field. Hence, his peer review record is a final emphasis of his exceptional role within the field of biochemistry.
  • Also, we included five recommendation letters to bolster his case further, whereas his extraordinary influence in the field is discussed by his fellow experts, proving that he is a scientist who is central to the discipline and has conducted research that has benefits for the well-being of those with cancer around the world. Therefore, one of his recommenders stated the below-mentioned:
“Overall, [client] has contributed extensively both to the field of biomedical science and the health of the nation at large. These contributions firmly place him at the very top of the field and thus I strongly support his continued research in the United States.”

Our team’s efforts successfully paid off in conveying to the USCIS that our client’s expansive experience in the field of biomedicine has afforded him vast knowledge and formidable skills, which are a significant asset to any research setting and thus set him apart as a valuable researcher in the biomedicine field today. We would like to congratulate him for securing both I-140 approvals and retaining us for his I-485 as well. We truly wish him the best in all his future endeavors.